Ameren Targets Lifted to $116, $127 and $113 on Growth Forecasts
Morgan Stanley raised its Ameren price target to $116 from $108 with an Equal Weight rating, citing January utilities underperformance and a balanced Q4 outlook on data center pipelines and affordability. UBS raised its Buy target to $127; Wells Fargo lifted its Overweight goal to $113, forecasting 8.4% EPS growth.
1. Morgan Stanley Equal Weight Rating
On February 20, Morgan Stanley raised its price objective for Ameren to $116 from $108 while retaining an Equal Weight rating. The firm noted that utilities underperformed the S&P 500 in January and expects a balanced Q4 outlook driven by data center pipeline developments and affordability considerations.
2. UBS Maintains Buy with Higher Target
Also on February 20, UBS analyst William Appicelli lifted Ameren’s price objective from $125 to $127 and upheld a Buy rating. The increase reflects confidence in Ameren’s regulated utility segments and stable cash flow profile.
3. Wells Fargo Overweight Rating and EPS Forecast
Wells Fargo boosted its price target to $113 from $111 and maintained an Overweight rating after Ameren’s slight Q4 earnings beat. The firm projects 8.4% EPS growth, noting management’s pathway to exceed 8% annual earnings expansion.